Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The cardiomyopathies are a heterogeneous collection of heart muscle disorders with diverse genetic and non-genetic aetiologies. The advent of next-generation sequencing has transformed our understanding of the mechanisms of disease underlying many forms of cardiomyopathy, accelerated clinical testing capacity and unlocked the prospect of personalized medicine based on knowledge of an individual's genetic variants. Cardiovascular imaging with echocardiography and cardiac magnetic resonance imaging plays a fundamental role in diagnosis, risk stratification and therapy guidance in the cardiomyopathies. The current management of patients with inherited cardiomyopathies is beginning to integrate knowledge of individual genomic profiles with advances in cardiovascular imaging. This has enhanced surveillance potential for high-risk individuals and begun to facilitate diagnosis, appropriate risk stratification and prognostication. This review introduces the cardiomyopathies, focusing on hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic cardiomyopathy and left ventricular non-compaction, giving an overview of their aetiological complexity, diagnosis and contemporary clinical management.

Original publication

DOI

10.1016/j.mpmed.2022.05.004

Type

Journal

Medicine (United Kingdom)

Publication Date

01/08/2022

Volume

50

Pages

492 - 506